Trillium TTI-621-03

Clinical Trial Grant

Duke Scholars

Principal Investigator Richard Francis Riedel Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

PF Argentum IP Holdings LLC

Start Date

February 15, 2022

End Date

October 19, 2026

Administered By

Duke Cancer Institute

Awarded By

PF Argentum IP Holdings LLC

Start Date

February 15, 2022

End Date

October 19, 2026